A common polymorphism in TLR3 confers natural resistance to HIV-1 infection

Journal of Immunology

Volumn 188, Issue 2, 2012, Pages 818-823

  Sironi, Manuela ^a   Biasin, Mara ^b   Cagliani, Rachele ^a   Forni, Diego ^a   De Luca, Mariacristina ^b   Saulle, Irma ^b   Lo Caputo, Sergio ^c   Mazzotta, Francesco ^c   Macías, Juan ^d   Pineda, Juan A ^d   Caruz, Antonio ^e   Clerici, Mario ^f  

^a Scientific Institute for Recovery and Care E Medea   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

^d HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^e UNIVERSITY OF JAÉN   (Spain)

^f IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD69 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MESSENGER RNA; TOLL LIKE RECEPTOR 3; TUMOR NECROSIS FACTOR ALPHA;

ALLELE; ANTIGEN EXPRESSION; ANTIGEN FUNCTION; ARTICLE; CD4+ T LYMPHOCYTE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ETHNIC GROUP; GENE EXPRESSION REGULATION; GENETIC POLYMORPHISM; GENOTYPE; HEPATITIS C VIRUS; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE RESPONSE; IN VITRO STUDY; INFECTION RESISTANCE; INFECTION SENSITIVITY; INTRAVENOUS DRUG ABUSE; ITALIAN; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SERODIAGNOSIS; SEXUAL TRANSMISSION; SPANISH; T LYMPHOCYTE; UPREGULATION; VIRUS REPLICATION;

CELLS, CULTURED; COHORT STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HIV INFECTIONS; HIV SERONEGATIVITY; HUMANS; ITALY; LEUCINE; MALE; PHENYLALANINE; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; SPAIN; TOLL-LIKE RECEPTOR 3;

EID: 84856013847     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102179     Document Type: Article

References (29)

1. Akira, S., S. Uematsu, and O. Takeuchi. 2006. Pathogen recognition and innate immunity. Cell 124: 783-801. (Pubitemid 43261452)
2. Choe, J., M. S. Kelker, and I. A. Wilson. 2005. Crystal structure of human toll-like receptor 3 (TLR3) ectodomain. Science 309: 581-585. (Pubitemid 41033635)
3. Barreiro, L. B., M. Ben-Ali, H. Quach, G. Laval, E. Patin, J. K. Pickrell, C. Bouchier, M. Tichit, O. Neyrolles, B. Gicquel, et al. 2009. Evolutionary dynamics of human Toll-like receptors and their different contributions to host defense. PLoS Genet. 5: e1000562.
4. Ranjith-Kumar, C. T., W. Miller, J. Sun, J. Xiong, J. Santos, I. Yarbrough, R. J. Lamb, J. Mills, K. E. Duffy, S. Hoose, et al. 2007. Effects of single nucleotide polymorphisms on Toll-like receptor 3 activity and expression in cultured cells. J. Biol. Chem. 282: 17696-17705. (Pubitemid 47100325)
5. Gorbea, C., K. A. Makar, M. Pauschinger, G. Pratt, J. L. Bersola, J. Varela, R. M. David, L. Banks, C. H. Huang, H. Li, et al. 2010. A role for Toll-like receptor 3 variants in host susceptibility to enteroviral myocarditis and dilated cardiomyopathy. J. Biol. Chem. 285: 23208-23223.
6. Kindberg, E., S. Vene, A. Mickiene, A. Lundkvist, L. Lindquist, and L. Svensson. 2011. A functional Toll-like receptor 3 gene (TLR3) may be a risk factor for tick-borne encephalitis virus (TBEV) infection. J. Infect. Dis. 203: 523-528.
7. Biasin, M., L. Piacentini, S. Lo Caputo, V. Naddeo, P. Pierotti, M. Borelli, D. Trabattoni, F. Mazzotta, G. M. Shearer, and M. Clerici. 2010. TLR activation pathways in HIV-1-exposed seronegative individuals. J. Immunol. 184: 2710-2717.
8. Clerici, M., J. A. Berzofsky, G. M. Shearer, and C. O. Tackett. 1991. Exposure to human immunodeficiency virus (HIV) type I indicated by HIV-specific T helper cell responses before detection of infection by polymerase chain reaction and serum antibodies [corrected]. J. Infect. Dis. 164: 178-182.
9. Clerici, M., J. V. Giorgi, C. C. Chou, V. K. Gudeman, J. A. Zack, P. Gupta, H-N. Ho, P. G. Nishanian, J. A. Berzofsky, and G. M. Shearer. 1992. Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1. J. Infect. Dis. 165: 1012-1019.
10. Miyazawa, M., L. Lopalco, F. Mazzotta, S. Lo Caputo, F. Veas, and M. Clerici; ESN Study Group. 2009. The 'immunologic advantage' of HIV-exposed sero-negative individuals. AIDS 23: 161-175.
11. Piacentini, L., M. Biasin, C. Fenizia, and M. Clerici. 2009. Genetic correlates of protection against HIV infection: the ally within. J. Intern. Med. 265: 110-124.
12. Beretta, A., S. H. Weiss, G. Rappocciolo, R. Mayur, C. De Santis, J. Quirinale, A. Cosma, P. Robbioni, G. M. Shearer, J. A. Berzofsky, et al. 1996. Human immunodeficiency virus type 1 (HIV-1)-seronegative injection drug users at risk for HIVexposure have antibodies to HLA class I antigens and T cells specific for HIV envelope. J. Infect. Dis. 173: 472-476. (Pubitemid 26042453)
13. Missé, D., H. Yssel, D. Trabattoni, C. Oblet, S. Lo Caputo, F. Mazzotta, J. Pène, J. P. Gonzalez, M. Clerici, and F. Veas. 2007. IL-22 participates in an innate anti- HIV-1 host-resistance network through acute-phase protein induction. J. Immunol. 178: 407-415.
14. de la Torre, M. S., C. Torres, G. Nieto, S. Vergara, A. J. Carrero, J. Macías, J. A. Pineda, A. Caruz, and J. Fibla. 2008. Vitamin D receptor gene haplotypes and susceptibility to HIV-1 infection in injection drug users. J. Infect. Dis. 197: 405-410.
15. Purcell, S., B. Neale, K. Todd-Brown, L. Thomas, M. A. Ferreira, D. Bender, J. Maller, P. Sklar, P. I. de Bakker, M. J. Daly, and P. C. Sham. 2007. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81: 559-575. (Pubitemid 47330214)
16. Qi, R., S. Hoose, J. Schreiter, K. V. Sawant, R. Lamb, C. T. Ranjith-Kumar, J. Mills, L. San Mateo, J. L. Jordan, and C. C. Kao. 2010. Secretion of the human Toll-like receptor 3 ectodomain is affected by single nucleotide polymorphisms and regulated by Unc93b1. J. Biol. Chem. 285: 36635-36644.
17. Hardarson, H. S., J. S. Baker, Z. Yang, E. Purevjav, C. H. Huang, L. Alexopoulou, N. Li, R. A. Flavell, N. E. Bowles, and J. G. Vallejo. 2007. Toll-like receptor 3 is an essential component of the innate stress response in virus-induced cardiac injury. Am. J. Physiol. Heart Circ. Physiol. 292: H251-H258. (Pubitemid 46105186)
18. Richer, M. J., D. J. Lavallée, I. Shanina, and M. S. Horwitz. 2009. Toll-like receptor 3 signaling on macrophages is required for survival following cox-sackievirus B4 infection. PLoS ONE 4: e4127.
19. Daffis, S., M. A. Samuel, M. S. Suthar, M. Gale, Jr., and M. S. Diamond. 2008. Toll-like receptor 3 has a protective role against West Nile virus infection. J. Virol. 82: 10349-10358. (Pubitemid 352691152)
20. Tabeta, K., P. Georgel, E. Janssen, X. Du, K. Hoebe, K. Crozat, S. Mudd, L. Shamel, S. Sovath, J. Goode, et al. 2004. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc. Natl. Acad. Sci. USA 101: 3516-3521. (Pubitemid 38338227)
21. Wang, T., T. Town, L. Alexopoulou, J. F. Anderson, E. Fikrig, and R. A. Flavell. 2004. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat. Med. 10: 1366-1373. (Pubitemid 40022719)
22. Le Goffic, R., V. Balloy, M. Lagranderie, L. Alexopoulou, N. Escriou, R. Flavell, M. Chignard, and M. Si-Tahar. 2006. Detrimental contribution of the Toll-like receptor (TLR)3 to influenza Avirus-induced acute pneumonia. PLoS Pathog. 2: e53.
23. Gowen, B. B., J. D. Hoopes, M. H. Wong, K. H. Jung, K. C. Isakson, L. Alexopoulou, R. A. Flavell, and R. W. Sidwell. 2006. TLR3 deletion limits mortality and disease severity due to Phlebovirus infection. J. Immunol. 177: 6301-6307. (Pubitemid 44628848)
24. Zhang, S. Y., E. Jouanguy, S. Ugolini, A. Smahi, G. Elain, P. Romero, D. Segal, V. Sancho-Shimizu, L. Lorenzo, A. Puel, et al. 2007. TLR3 deficiency in patients with herpes simplex encephalitis. Science 317: 1522-1527. (Pubitemid 47417427)
25. Lester, R. T., X. D. Yao, T. B. Ball, L. R. McKinnon, R. Kaul, C. Wachihi, W. Jaoko, F. A. Plummer, and K. L. Rosenthal. 2008. Toll-like receptor expression and responsiveness are increased in viraemic HIV-1 infection. AIDS 22: 685-694. (Pubitemid 351450636)
26. Jaekal, J., E. Abraham, T. Azam, M. G. Netea, C. A. Dinarello, J. S. Lim, Y. Yang, D. Y. Yoon, and S. H. Kim. 2007. Individual LPS responsiveness depends on the variation of toll-like receptor (TLR) expression level. J. Microbiol. Biotechnol. 17: 1862-1867. (Pubitemid 350238183)
27. Petit-Bertron, A. F., O. Tabary, H. Corvol, J. Jacquot, A. Clément, J. M. Cavaillon, and M. Adib-Conquy. 2008. Circulating and airway neutrophils in cystic fibrosis display different TLR expression and responsiveness to interleukin-10. Cytokine 41: 54-60.
28. Schoneveld, A. H., I. Hoefer, J. P. Sluijter, J. D. Laman, D. P. de Kleijn, and G. Pasterkamp. 2008. Atherosclerotic lesion development and Toll like receptor 2 and 4 responsiveness. Atherosclerosis 197: 95-104. (Pubitemid 351273277)
29. Cagliani, R., S. Riva, M. Fumagalli, M. Biasin, S. Lo Caputo, F. Mazzotta, L. Piacentini, U. Pozzoli, N. Bresolin, M. Clerici, and M. Sironi. 2011. A positively selected APOBEC3H haplotype is associated with natural resistance to HIV-1 infection. Evolution 65: 3311-3322.